Attenuation of Reactive Astrogliosis Accompanies Neurological Recovery Induced by Novel Poly-Target 2,3-Benzodiazepines After Experimental Traumatic Brain Injury
Novel poly-target 2,3-benzodiazepine derivatives, MPTD-01 and BS34-20, significantly improved neurological recovery and survival while attenuating reactive astrogliosis in a rat model of traumatic brain injury, supporting their potential as multi-target neuroprotective agents.